List of bibliographic references
Number of relevant bibliographic references: 2.
List of associated KwdEn.i
Nombre de documents | Descripteur |
2 | Adult |
2 | Aged |
2 | Aged, 80 and over |
2 | Biphenyl Compounds (administration & dosage) |
2 | Biphenyl Compounds (adverse effects) |
2 | Carcinoma, Basal Cell (drug therapy) |
2 | Double-Blind Method |
2 | Female |
2 | Humans |
2 | Male |
2 | Middle Aged |
2 | Pyridines (administration & dosage) |
2 | Pyridines (adverse effects) |
2 | Skin Neoplasms (drug therapy) |
2 | Skin Neoplasms (pathology) |
1 | Antineoplastic Agents (administration & dosage) |
1 | Antineoplastic Agents (adverse effects) |
1 | Antineoplastic Agents (therapeutic use) |
1 | Biphenyl Compounds (therapeutic use) |
1 | Carcinoma, Basal Cell (pathology) |
1 | Carcinoma, Basal Cell (radiotherapy) |
1 | Carcinoma, Basal Cell (secondary) |
1 | Carcinoma, Basal Cell (surgery) |
1 | Disease Progression |
1 | Disease-Free Survival |
1 | Kaplan-Meier Estimate |
1 | Neoplasm Metastasis |
1 | Neoplasm Recurrence, Local (drug therapy) |
1 | Neoplasm Recurrence, Local (pathology) |
1 | Neoplasm Recurrence, Local (radiotherapy) |
1 | Neoplasm Recurrence, Local (surgery) |
1 | Pyridines (therapeutic use) |
1 | Skin Neoplasms (radiotherapy) |
1 | Skin Neoplasms (surgery) |
1 | Smoothened Receptor (antagonists & inhibitors) |
1 | Survival Rate |
1 | Treatment Outcome |
1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "John T. Lear"
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i \
-Sk "John T. Lear" \
| HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= UK
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= John T. Lear
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |